Concepedia

Helen Brandt

HB

Statistics

Publications

1

Citations

103

H-Index

1

Active since

2003

Affiliations

Wayne State University(Current)

Helen Brandt is an author at Wayne State University specializing in tyrosine kinase inhibitor therapy, bcr-abl inhibitors, and dose escalation.

Publications per year

2003–2003

1

Publications

1

The effect of dose increase of imatinib mesylate in patients with chronic or accelerated phase chronic myelogenous leukemia with inadequate hematologic or cytogenetic response to initial treatment.

Jeffrey A. Zonder, Pamela Pemberton, Helen Brandt et al. · PubMed · 2003 · 103 citations

, , +14

1–1 of 1